Maze Therapeutics, Inc. Common Stock (MAZE) net margin is 33.0%
Maze Therapeutics, Inc. Common Stock (MAZE) net margin is 33.0% as of 2025-06-30. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full MAZE research page for quote, filings, and the rest of the model. This satellite exists so “Maze Therapeutics, Inc. Common Stock net margin” can rank with the actual number, then send you to /stock/maze.